Latest updates for Fda Approved
Fresh curated links around FDA approved are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- <![CDATA[Pharmaceutical Executive Daily: FDA Approves Datroway]]>
- <![CDATA[FDA Approves Foundayo Under National Priority Voucher Program]]>
- New Weight Loss Pill Gets Approval But FDA Seeks More Safety Data
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
<![CDATA[FDA Approves Foundayo Under National Priority Voucher Program]]>
New Weight Loss Pill Gets Approval But FDA Seeks More Safety Data
WEDNESDAY, April 15, 2026 — The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity drug Foundayo, ac...
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Hepcludex]]>
New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
WEDNESDAY, April 15, 2026 — The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity drug Foundayo, acc...
<![CDATA[FDA Approves Hepcludex as First and Only Approved Treatment for Chronic Hepatitis Delta Virus]]>
<![CDATA[Travere Therapeutics’ Filspari Receives Full FDA Approval ]]>
<![CDATA[FDA Approves Caplyta for Prevention of Schizophrenia in Adults ]]>
<![CDATA[FDA Approves Bizengri for Adults with NRG1 Fusion-Positive Cholangiocarcinoma]]>
<![CDATA[FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhi...
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Auvelity]]>
<![CDATA[Pharmaceutical Executive Daily: Idvynso Receives FDA Approval]]>
<![CDATA[FDA Approves Idvynso for Treatment of HIV-1 Infection in Adults]]>
FDA Approves First Generic Farxiga (dapagliflozin) Tablets
April 7, 2026 -- The U.S. Food and Drug Administration approved the first generics of Farxiga (dapagliflozin) tablets to reduce the risk of hospitalization for heart failure in adu...
<![CDATA[FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection ]]>
<![CDATA[FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry]]>
FDA Approves New Weight Loss Pill, Foundayo, in Record Time
THURSDAY, April 2, 2026 — A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved through review faster than most d...
<![CDATA[FDA Issues CRL to AbbVie for TrenibotulinumtoxinE’s Biologics License Application ]]>
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Beqalzi and Inqovi]]>
New Foundayo weight loss pill approved by FDA. Here’s what it costs and how it compares to Zepbound
The FDA authorized Eli Lilly's drug as part of a new program aimed at cutting drug approval times
FDA grants breakthrough designation for efimosfermin for MASH
The FDA granted breakthrough therapy designation to efimosfermin — an investigational, once-monthly fibroblast growth factor 21 analogue — for treatment of patients with metabolic...
<![CDATA[FDA Approves Fasenra for Hypereosinophilic Syndrome]]>
<![CDATA[FDA Approves Auvelity for Treatment of Agitation Associated with Dementia Due to Alzheimers]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.